Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Supernus Pharm (SUPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,516,522
  • Shares Outstanding, K 52,210
  • Annual Sales, $ 302,240 K
  • Annual Income, $ 57,280 K
  • 36-Month Beta 0.79
  • Price/Sales 8.28
  • Price/Cash Flow 32.93
  • Price/Book 6.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.44
  • Number of Estimates 7
  • High Estimate 0.49
  • Low Estimate 0.37
  • Prior Year 0.29
  • Growth Rate Est. (year over year) +51.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.99 +4.81%
on 10/16/18
51.38 -6.19%
on 10/01/18
+0.30 (+0.63%)
since 09/19/18
3-Month
41.80 +15.31%
on 08/14/18
56.40 -14.54%
on 07/24/18
-6.05 (-11.15%)
since 07/19/18
52-Week
33.30 +44.74%
on 11/07/17
61.25 -21.31%
on 06/29/18
+5.60 (+13.15%)
since 10/19/17

Most Recent Stories

More News
Supernus Pharmaceuticals (SUPN): Moving Average Crossover Alert

Supernus Pharmaceuticals, Inc. (SUPN) could be a stock to avoid from a technical perspective

SUPN : 48.20 (+0.61%)
Watch for Shares of Nike Inc -Cl B (NKE) to Approach Resistance at $78.33

Nike Inc -Cl B (NYSE:NKE) has opened bullishly above the pivot of $75.16 today and has reached the first level of resistance at $76.42. Should the shares continue to rise, the resistance pivots of $78.33...

SUPN : 48.20 (+0.61%)
NKE : 74.21 (-1.84%)
OCUL : 6.17 (-0.16%)
New Strong Sell Stocks for October 10th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

POST : 95.78 (+0.86%)
ADNT : 30.19 (+1.58%)
SUPN : 48.20 (+0.61%)
WYNN : 110.20 (-3.22%)
VOD : 20.20 (+1.46%)
New Research Coverage Highlights Randgold Resources, California Water Service Group Holding, B&G Foods, Hawaiian, Bank of Nova Scotia, and Supernus Pharmaceuticals -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Randgold Resources Limited...

GOLD : 81.93 (+0.37%)
CWT : 42.31 (+0.81%)
BNS : 54.23 (-0.70%)
SUPN : 48.20 (+0.61%)
HA : 34.23 (+0.53%)
BGS : 27.33 (+2.36%)
Supernus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced...

SUPN : 48.20 (+0.61%)
Supernus to Acquire Biscayne Neurotherapeutics

Adds Phase 1 Novel Epilepsy Development Program

SUPN : 48.20 (+0.61%)
Neos Therapeutic is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (NEOS , SUPN , OCUL , LCI , ZGNX )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

SUPN : 48.20 (+0.61%)
NEOS : 4.15 (+2.72%)
OCUL : 6.17 (-0.16%)
Supernus Wins Appeal on Oxtellar XR(R) against TWi

Second Appeal Win against Generic Filers

SUPN : 48.20 (+0.61%)
Supernus Pharmac has the Best Relative Performance in the Pharmaceuticals Industry (SUPN , OCUL , JNJ , BMY , PBH )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

JNJ : 139.05 (-0.32%)
SUPN : 48.20 (+0.61%)
OCUL : 6.17 (-0.16%)
Endocyte Inc has the Best Relative Performance in the Pharmaceuticals Industry (ECYT, PRGO , SUPN , COLL , PRTK )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

SUPN : 48.20 (+0.61%)
ECYT : 23.48 (+0.34%)
PRGO : 71.89 (-0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade SUPN with:

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

2nd Resistance Point 49.19
1st Resistance Point 48.69
Last Price 48.20
1st Support Level 47.80
2nd Support Level 47.41

See More

52-Week High 61.25
Fibonacci 61.8% 50.57
Last Price 48.20
Fibonacci 50% 47.28
Fibonacci 38.2% 43.98
52-Week Low 33.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar